Authors
A Du Bois, Michael Quinn, T Thigpen, J Vermorken, E Avall-Lundqvist, M Bookman, D Bowtell, M Brady, A Casado, A Cervantes, E Eisenhauer, M Friedlaender, K Fujiwara, S Grenman, JP Guastalla, P Harper, T Hogberg, S Kaye, H Kitchener, G Kristensen, R Mannel, W Meier, B Miller, JP Neijt, A Oza, R Ozols, M Parmar, Sergio Pecorelli, J Pfisterer, A Poveda, D Provencher, E Pujade-Lauraine, M Randall, J Rochon, G Rustin, S Sagae, F Stehman, G Stuart, E Trimble, P Vasey, I Vergote, R Verheijen, U Wagner
Publication date
2005/1/1
Journal
Annals of oncology
Volume
16
Pages
viii7-viii12
Publisher
Elsevier
Description
Gynecological Cancer Intergroup (GCIG) and its member organizations: 1AGO-OVAR (Germany), 2ANZGOG (Australia–New Zealand), 4EORTC (Europe), 6GEICO (Spain), 9GINECO (France), 3GOG (USA), 8JGOG (Japan), 10MRC/NCRI (UK), 7NCIC-CTG (Canada), 15NCI-US (USA), 5NSGO (Scandinavia), 12RTOG (USA), 11SGCTG (Scotland), and with representation of 14IGCS and 13the organizational team of the two prior International OCCC
International evidence-based consensus statements are important in order to define and update standards of care and to serve not only as guidelines to communities worldwide, but also to provide a rational basis for future research. Two previous successful international ovarian cancer consensus conferences (OCCC) were held in Elsinore, Denmark in 1993 [1] and 5 years later in Bergen aan Zee, The Netherlands [2], where consensus statements were developed on a …
Total citations
20062007200820092010201120122013201420152016201720182019202020212022202320242025263247473344343428331920232419225